show episodes
 
Welcome to Talking 24, the health and information podcast from NHS 24, with your host Lisa Dransfield. From invaluable health information to patient stories and updates on clinical services development, Talking 24 is the ultimate health podcast for those living in Scotland. If you have anything you'd like us to talk about on the Podcast, please get in touch with us on social media Facebook https://www.facebook.com/NHS24/ Instagram https://www.instagram.com/nhs24.scot/ Twitter https://twitter ...
  continue reading
 
CAMHS Grampian is a NHS mental health service for under 18's, based in Grampian, Scotland. This podcast series is a psychoeducation 'top tips' collection, recorded by our very own staff, to make managing stress in tough times just that little bit easier. If you're under 18 in Grampian and want to improve your mental health, or are a parent and want to support your child or teen even better, this podcast could be for you! Please note that this podcast is NOT a substitute for face-to-face medi ...
  continue reading
 
Artwork
 
Musawo Julie (Dr.Juliet Nalubula) born 24/11/1988 in Uganda. is a versatile professional who began her career in dental surgery and worked with NHS Uk for 12years at Harley Street Dental. However, her passion for understanding the human mind led her to shift focus toward psychology. She pursued advanced studies in psychology and criminology in London, gaining deep insights into human behavior. Today, Musawo Julie is a global educator, teaching people how to improve their lives by applying ps ...
  continue reading
 
Artwork
 
Workers’ Liberty fights for socialist revolution, for the labour movement to militantly assert working class interests. Follow us! Find out more, and get involved at https://workersliberty.org • fb.me/workersliberty • twitter.com/workersliberty
  continue reading
 
Artwork
 
We talk to colleagues in the NHS and local government, as well as people with lived experience, to explore the different ways we can develop a new relationship between people and their health service. Personalisation? It’s all about people!
  continue reading
 
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
  continue reading
 
Artwork

1
People & Profit

FRANCE 24 English

Unsubscribe
Unsubscribe
Monthly+
 
The business show that goes beyond the numbers and the corporate jargon! We break down major business stories and look at how they affect our lives. Thursday at 4:45pm Paris time.
  continue reading
 
Ethics Untangled is a series of conversations about the ethical issues that affect all of us, with academics who have spent some time thinking about them. It is brought to you by the IDEA Centre, a specialist unit for teaching, research, training and consultancy in Applied Ethics at the University of Leeds. Find out more about IDEA, including our Masters programmes in Healthcare Ethics and Applied and Professional Ethics, our PhDs and our consultancy services, here: ahc.leeds.ac.uk/ethics Et ...
  continue reading
 
The UK Council for Psychotherapy (UKCP) is the UK’s leading professional body for the education, training and accreditation of psychotherapists and psychotherapeutic counsellors. Our membership includes over 7,800 individual therapists and more than 70 training and accrediting organisations.
  continue reading
 
Beyond the politics, beyond our geography are the intangible connections that hold us together - The We Society. The We Society podcast is here to tell you about the thousands of ways the Social Sciences can help us understand and enhance this complicated and fascinating human network. What can we do to fix the NHS? How can we better manage climate change? How do we end the cost of living crisis? Brought to you by the Academy of Social Sciences, this podcast tackles the big questions through ...
  continue reading
 
Loading …
show series
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Ascendis, Novo ink partnership The bad — Court blocks Sun Pharma launch The ugly — FDA moves to delist phenylephrineBy Pharma Manufacturing
  continue reading
 
Prepare to reflect! Alison chats to Karen (Cancer Lived Experience) and Vicky (CEO Every-One) about 'Living the Dash'. "These are the days" but are our systems and processes allowing us to live them? Are we making the most of our own "Gloriously Ordinary Life"? Karen is an inspiration. Listen now and give some thought to 'palliative', and the impac…
  continue reading
 
Solidarity 725, 13 November 2024. Articles: After Trump’s win, unite the left! Trump wins: redouble solidarity! Building a “critical mass” of protest Call PCS leaders to account Trump’s victory hangs over Ukraine Solidarity with Ukraine’s schools Will AI go bust? Fight university cuts, abolish fees The working class in the Blitz Referendums win des…
  continue reading
 
Solidarity 724, 6 November 2024. Articles: After the Reeves £40bn, anti-cuts fight still needed Defend democracy! Defend the US left, labour movement and minorities! Stop the school closures! RMT wrong to call off Tube strike Stop Gaza starving! Spain highlights climate emergency Nothing to fear from Trump? Georgians want democracy and a European f…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — MilliporeSigma expands ADC manufacturing The bad — EU fines Teva The ugly — AZ exec under investigationBy Pharma Manufacturing
  continue reading
 
Adam Byfield is Principal Technical Assurance Specialist at NHS England. His job involves providing ethical assurance for technical systems which are used in the NHS, including those which employ artificial intelligence. It's well known that AI, as well as providing some really exciting benefits, raises some distinctive ethical issues, but it was r…
  continue reading
 
Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as they discuss the urgency of tackling antimicrobial resistance and the coordinated global efforts needed to save the struggling market of antibiotics. Extended Release is an Off Script series to revisit con…
  continue reading
 
Solidarity 723, 30 October 2024. Articles: Stop the war! Two states! What would be a workers’ Budget? Ceasefire now! Civil service: fight “60%” rule After 26 October, organise against far right Support self-determination for Taiwan! A counterproductive protest Putin’s victory, Georgia’s nightmare Socialist answers on domestic violence Sheffield uni…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Nucleus RadioPharma expands production with new sites The bad — FDA issues CRL to Camurus' hormone disorder drug The ugly — NHS rejects Alzheimer's drug over cost concerns…
  continue reading
 
As the International Monetary Fund and World Bank mark 80 years since their founding, how can they stay relevant and effective? During the annual fall meeting in Washington, World Bank Senior Managing Director Axel van Trotsenburg told FRANCE 24 that reforms are underway, but need to happen more quickly. "I think an international organisation shoul…
  continue reading
 
Solidarity 722, 23 October 2024. Articles:Squeeze the millionaires!Gaza is starvingMarch against racism on 26 October!Employment Bill is too weakJustice and Chris KabaConfusion about investment and divestmentGaza: end the warIsrael out of Lebanon!Building solidarity and hopeEvolution Gaming: this strike mattersAre there no rights to defend in the U…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves AbbVie 24-hour Parkinson’s treatment The bad — Sage Therapeutics axes workforce The ugly — FDA halts Novavax's COVID-flu vaccine trialsBy Pharma Manufacturing
  continue reading
 
Should we be worried about teledildonics? *CONTENT WARNING. This episode contains frank descriptions of sexual practices of various kinds, and discussion of sexual assault and rape, including rape by deception.* Teledildonics is a word that refers to the use of networked electronic sex toys to facilitate sexual or quasi-sexual interactions between …
  continue reading
 
Just how sustainable is your happy hour? The beverage industry is among those facing pressure to mitigate its impact on the environment. In 2021, it accounted for 3.8 percent of global carbon emissions. We take a closer look in this edition of People & Profit. Drinks sustainability consultant Anne Jones says both packaging and raw materials are key…
  continue reading
 
Solidarity 721, 16 October 2024. Articles: Ceasefire, peace, two states Israel out of Lebanon! Take from the rich, rebuild society Some positives, but not good enough Anti-government protests in Israel Food and medical supplies worse in Gaza One year on from 7 October Socialist Worker returns to “Cairo” line Rape courts and half-measures Turkey’s d…
  continue reading
 
Caty leads us through a conversation with Hannah (manager) and Chris (volunteer) from the Askefield Social Farm project. Hear about the innovative ways that they are supporting wellbeing from babies to pensioners, how they've used different funding, what outcomes they have had for people and how volunteering has a real impact on people's health. It…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Roche snags breast cancer FDA nod The bad — FDA places clinical hold on Kezar lupus nephritis drug trial The ugly — FDA rejects Zealand Pharma hypoglycemia drug over manufacturing reinspection…
  continue reading
 
Can European industry regain its competitive edge on the global stage? A new EU report penned by former ECB chief Mario Draghi highlights a growing gap in both productivity and innovation, and warns that businesses will face an "existential challenge" without drastic change and significant investment. Tim Figures, a partner and associate director a…
  continue reading
 
Solidarity 720, 9 October 2024. Articles include: Home is where the heartache is Their wealth, our poverty Students face campus clampdowns Chagos deal is a sell-out Halt the spreading war! Standing Together after a year of war Trump and Huey Long If Trump wins, this is why Stop Gaza-Lebanon horror! Ceasefire, peace! Israel’s religious right pushes …
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Gilead inks deal with generics manufacturers to expand HIV drug access The bad — J&J announces layoffs at New Brunswick headquarters The ugly — Amgen sued for hiding $10.7B tax bill…
  continue reading
 
So, you think that you know sleep is important but then... Matt is joined by Becky (School teacher and Sleep Practitioner) and Adrian (CEO, British Society of Pharmacy Sleep Services) for a discussion about sleep including the importance of routines, impact on children, blue light myths and over-the-counter sleep aids. Both guests live and work in …
  continue reading
 
Alex Batesmith has had a fascinating career. After beginning as a criminal barrister in Leeds, he went on to work as a United Nations prosecutor in Cambodia and Kosovo, working on cases involving genocide, crimes against humanity and war crimes. He's now a legal scholar working at Leeds University, and has been researching the values and motivation…
  continue reading
 
The French government plans to subject the budget to a €60 billion belt-tightening drive next year in the hope of bringing the deficit down to 5 percent of GDP from an estimated more than 6 percent this year. Two-thirds of that sum are to come from spending cuts, and the rest from new taxes. Why does the country find itself in this fiscal hole? How…
  continue reading
 
Solidarity 719, 2 October 2024. Articles include most of: The dangers now in Sri Lanka Asylum: defeat the “Meloni model” Kino Eye: Forty years since Threads Far-right surge in Austria Ukraine: a changing "analysis" Legal challenges to rats, mould, damp, high rents Kyaw Nyein and the "Third Camp" Free Phoebe and Anna! Solidarity with Haifa students …
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good —FDA approves BMS schizophrenia drug The bad — bluebird bio announces layoffs The ugly —J&J talc subsidiary files for bankruptcyBy Pharma Manufacturing
  continue reading
 
In the first of this two-parter, Matt is joined by Ed (Practice Advisor, Children's Services) and Ela (Improvement Practice Lead and Expert by Experience) from Lincolnshire County Council to learn about anti-racist practice. We hear some difficult local realities and we find out some of the work that is going on to make things better for people liv…
  continue reading
 
Women's Fightback 32, Autumn-Winter 2024. Inside: Labour in Power: What Next? — Editorial Pride in Labour? — An interview with Max O'Hara & Sacha Marten Labour Won't Save the NHS — Elaine Jones Justice for Justine & Jay — Jesse Michaels Slip — An Interview with Amelia Loulli Abortion is Healthcare: demo report — Sabrina Rahma Duale Free Speech and …
  continue reading
 
This week we look at ethical fashion in the age of "direct-to-consumer" giants like China's Shein and Temu. Thanks to their business model based on ultra-fast design and production, consumers can purchase a new look at incredibly low prices. But at what cost for the environment and worker wellbeing? Charles Pellegrin talks to Kamila Boudova, a Pari…
  continue reading
 
Join senior editor Andrea Corona and Sam Clark, CEO and founder of Terran Biosciences, for a discussion on KarXT's landmark approval, schizophrenia treatment barriers, prodrugs, and more. Extended Release is an Off Script series that allows us to revisit conversations with our sources to explore new developments, gain deeper insights, and provide u…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Novo Nordisk shares phase 2a trial data for obesity treatment The bad — Achilles Therapeutics to discontinue TIL-based therapy The ugly — Express Scripts files lawsuit against FTC…
  continue reading
 
Drugmakers face stringent regulations to ensure that products remain free from contaminants that could compromise safety and efficacy. Effective contamination control requires meticulous monitoring of environmental conditions, rigorous testing of products, and implementation of robust cleaning and sterilization procedures. To better understand thes…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Roche snags FDA nod for subcutaneous cancer immunotherapy The bad — Moderna to cut R&D expenses by $1.1B The ugly — Teva reaches $80M opioid settlement with Baltimore…
  continue reading
 
Gender is, of course, one of the most contentious ethical and political topics you can find at the moment. There are numerous practical and policy debates - for example those relating to medicine, prisons and sport - which can seem completely intractable, and which provoke the strongest possible opinions on all sides. Sitting behind these practical…
  continue reading
 
The athletes have crossed the finish line of the Paris Olympic and Paralympic Games. Now economists are trying their best to accurately assess the economic impact of this global event on the city and on France. Our guest, Wladimir Andreff, is one of them. He is a specialist of sports economics and a professor emeritus at the university of Paris Pan…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer, Valneva share phase 2 positive Lyme vax data The bad — IN8bio axes workforce, halts trial The ugly — AstraZeneca employees detained in ChinaBy Pharma Manufacturing
  continue reading
 
Time for a bit of an update so whilst Matt and Alison wrestle for 'microphone control', Gav slips in to share his passion for Our Shared Agreement and in particular the improved relationship between people and the system. Together, they chat chat about It's All About People Champions, ways to capture stories and some of the challenges being faced t…
  continue reading
 
Solidarity 718, 4 September 2024. Articles include:Debate: Labour Party story is more complexSocialist Worker accepts Maduro's rigged poll figuresTOCs drivers' dispute: offer is progress, but it's still a pay cut - we can win more!Banks, billions, and profitsThreat rises of wider warGeneral strike in Israel demands ceasefire dealMorning Star doesn’…
  continue reading
 
Loading …

Quick Reference Guide